Sign in to view content

Evaluation of Baseline Characteristics on Lesion Progression in a Large Phase 2 Clinical Trial for Geographic Atrophy (FILLY Study)

Eleonora Lad, MD, PhD

Video
Published 2019

Eleonora Lad

AMD Non-neovascular Symposium

Related

Avacincaptad Pegol, A Novel C5 Inhibitor, and GATHER1 Study: Results From a Post-Hoc Analysis of Nascent Geographic Atrophy
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2021
Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD
Annual Meeting Talks
2022
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
Updates from the Field
2021

Category: AMD-Non-Neovascular

See more